(19)

(11)

EP 4 798 238 A2

(12)

(88) Date of publication A3: 19.06.2025 (43) Date of publication: 02.09.2026 Bulletin 2026/36 (21) Application number: 24805031.2 (22) Date of filing: 25.10.2024

(51) International Patent Classification (IPC):  A61K 39/395(2006.01) C07K 16/24(2006.01) A61P 37/02(2006.01) (52) Cooperative Patent Classification (CPC): A61K 39/3955; A61P 37/02; C07K 16/244; C07K 2317/56; C07K 2317/92; C07K 2317/94; C07K 2317/622; C07K 2317/76; A61K 2039/505; C07K 2317/21; C07K 2317/90 (86) International application number: PCT/US2024/053025 (87) International publication number: WO 2025/090910 (01.05.2025 Gazette 2025/18)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 25.10.2023 US 202363593199 P (71) Applicant: Multiverse Pharma Inc. Poway, California 92064 (US)	(72) Inventors: BENNETT, Brydon Poway, California 92064 (US) HUNG, Fu-Hsin Poway, California 92064 (US) SUN, Jeonghoon Poway, California 92064 (US) (74) Representative: De Clercq & Partners  Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem 9830 Sint-Martens-Latem (BE)